Description: Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the field of neuroscience.
neuroscience (650) oncology (581) neurology (386) orphan (226) schizophrenia (197) bipolar i disorder (9) lybalvi alks 1140 lybalvi™ (olanzapine and samidorphan) nemvaleukin alfa
Discover Alkermes
May 16, 2023 Alkermes Highlights Data From Psychiatry Portfolio at Spring 2023 Scientific Conferences
May 09, 2023 Alkermes Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting